Efavirenz pharmacokinetics in HIV-1-infected children are associated with CYP2B6-G516T polymorphism. [electronic resource]
Producer: 20070928Description: 280-5 p. digitalISSN:- 1525-4135
- Alkynes
- Anti-HIV Agents -- pharmacokinetics
- Antiretroviral Therapy, Highly Active
- Aryl Hydrocarbon Hydroxylases -- genetics
- Benzoxazines -- pharmacokinetics
- Child
- Child, Preschool
- Cyclopropanes
- Cytochrome P-450 CYP2B6
- Drug Resistance, Viral
- Female
- Genotype
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Male
- Oxidoreductases, N-Demethylating -- genetics
- Polymorphism, Genetic -- genetics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.